Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

J. M. Jürgensmeier H-J Schmoll; J. D Robertson; L Brooks; M Taboada; S. R Morgan; D Wilson; P. M Hoff

British Journal of Cancer London v. 108, n. 6, p. 1316-1323, 2013

London 2013

Localização: FM - Fac. Medicina    (BCSEP 155 2013 )(Acessar)